Stock comparison
Sotera Health
SHC
Market cap
$4.45B
Sector
Healthcare
Overall winner
Sotera Health
SHC 6–1 TMO
Thermo Fisher Scientific
TMO
Market cap
$175.7B
Sector
Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
SHCvsTMO
58D
52C
84D
74B
53C
40D
36D
28F
30F
51D
60D
52D
58D
45D
Side-by-side metrics
| Metric | SHC | TMO |
|---|---|---|
| Market cap | $4.45B | $175.7B |
| P/E (TTM) | 36.9x | 26.4x |
| EV/EBIT | 16.1x | 27.2x |
| ROIC (TTM) | 7.96% | 7.33% |
| Gross margin | 55.01% | 39.41% |
| Net margin | 9.91% | 15.18% |
| Revenue CAGR 5y | 5.72% | 3.25% |
| EPS CAGR 5y | -9.92% | -2.43% |
| Debt / Equity | 3.6x | 0.8x |
| Dividend yield | 0.0% | 0.36% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
SHC leads on
- Revenue CAGR 5y5.72%vs 3.25%+43%
- EV/EBIT16.1xvs 27.2x+41%
- Gross margin55.01%vs 39.41%+28%
- ROIC (TTM)7.96%vs 7.33%+8%
TMO leads on
- Dividend yield0.36%vs 0.0%+100%
- Market cap$175.7Bvs $4.45B+97%
- Debt / Equity0.8xvs 3.6x+77%
- EPS CAGR 5y-2.43%vs -9.92%+75%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.